Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Humacyte, Inc. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2023-06-07 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
Proposal 2 – Ratification of the Selection of Independent Registered Public Accounting Firm. The appointment of Pricewaterhouse Coopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified. The results of stockholders’ votes on this matter were as follows: For Against Abstain 61,686,786 59,411 14,577 There were no broker non-votes on this proposal.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Humacyte, Inc. shareholders approved Election of Class II Directors at the 2023-06-07 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
The stockholders elected each of the four Class II directors who were nominated to serve until the Company’s 2026 annual meeting of stockholders or until such director’s successor is elected, or until such director’s earlier death, resignation or removal. The results of stockholders’ votes on this matter were as follows: Nominee For Withheld Broker Non-Votes Gordon M. Binder 53,072,579 614,973 8,073,222 Todd M. Pope 53,537,054 150,498 8,073,222 Kathleen Sebelius 49,175,215 4,512,337 8,073,222 Rajiv Shukla 52,859,609 827,943 8,073,222
View on SEC.gov